Page last updated: 2024-08-24

lamivudine and HIV

lamivudine has been researched along with HIV in 160 studies

*HIV: Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. [MeSH]

Research

Studies (160)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's35 (21.88)18.2507
2000's62 (38.75)29.6817
2010's52 (32.50)24.3611
2020's11 (6.88)2.80

Authors

AuthorsStudies
Cheng, YC; Chu, CK; Du, J; Lin, JS; Newton, MG; Schinazi, RF; Surzhykov, S1
Chen, SH; Cheng, YC; Doyle, TW; Dutschman, GE; Gullen, EA; King, I; Mao, J; Wang, Q1
Gochfeld, DJ; Hamann, MT1
Austin, DJ; Cheng, YC; Chung, R; Dutschman, GE; Fu, L; Gullen, EA; Huang, ES; Lee, Y; Li, Y; Yeo, H; Zhu, JL1
Chen, FE; Gu, SX; Liu, GY; Meng, G; Pannecouque, C; Tang, JF; Wu, FS; Xiao, T; Xu, ZQ; Zhu, YY1
Motiee, F; Sohrabi, MR; Valaee, M1
Eleje, GU; Ikechebelu, JI; Nwagha, UI; Okafor, HU; Ugwu, AO; Ugwu, EO; Umeh, UA1
Cai, W; Gu, F; Guo, P; He, Y; Hu, F; Lan, Y; Li, H; Li, L; Li, Y; Lin, W; Tang, X; Zhong, H1
George, PE; Mercedes, R; Nabukeera-Barungi, N; Otto, SBJ1
Davis, CC; Hassounah, S; Heredia, A; Kashanchi, F; Le, NM; Medina-Moreno, S; Mesplede, T; Oliveira, M; Zapata, JC1
Jianwei, L; Menghua, W; Qinwei, Y; Xin, Z; Yu, Z1
Belmonti, S; Borghetti, A; Ciccullo, A; Di Giambenedetto, S; Fabbiani, M; Lombardi, F1
Cao, TZ; He, Y; Liu, JY; Liu, XN; Rao, M; Song, Y; Sun, LQ; Tian, YM; Wang, H; Xu, LM; Zhang, LK; Zhao, F; Zhou, Y1
Basu, A; Biswas, A; Das, BK; Nischal, N; Soneja, M; Sood, R; Wig, N1
Cassim, H; Gray, GE; Greeff, OBW; Lazarus, E; Liberty, A; Otwombe, K; Violari, A1
Bernheimer, J; Fairlie, L; Fick, C; Kuhn, L; Sipambo, N1
Cochrane, S; Daniel, J; Forsyth, S; Smit, E1
Alfredo, C; Auld, A; Bhatt, N; Bila, D; Buck, WC; Cossa, L; DeVos, J; Houston, J; Jani, I; Jobarteh, K; Macassa, E; Sabatier, J; Sousa, A; Vaz, P; Yang, C1
Chen, QY; Fang, ZL; Harrison, TJ; Hu, LP; Jia, HH; Li, KW; Liang, SJ; Ren, CC; Wang, C; Wang, XY; Yang, QL1
Naing, C; Poovorawan, Y; Tong, KS1
Kan, W; Leng, X; Liao, L; Liu, P; Ruan, Y; Shao, Y; Wang, J; Xing, H; Xu, W; Yan, J; You, Y; Zuo, Z1
Rijnders, BJA; Rokx, C1
Bai, F; Battisti, A; Bavaro, DF; Bezenchek, A; De Luca, A; Di Carlo, D; Di Giambenedetto, S; Gagliardini, R; Giachè, S; Incardona, F; Lo Caputo, S; Pecorari, M; Salomoni, E; Zazzi, M; Zuccalà, P1
Archary, M; Bobat, R; Hennig, S; LaRussa, P; Mcllleron, H; Sibaya, T; Wiesner, L1
Briñón, MC; Esteve-Romero, J; Gualdesi, MS; Raviolo, MA1
Arnett, DK; Bagchi, S; Chi, BH; Heimburger, DC; Kabagambe, EK; Kiage, JN; Koethe, JR; Nyirenda, CK; Wellons, MF1
Abbas, SQ; Abro, AG; Baig-Ansari, N; Kazi, MA; Mir, F; Qamar, FN; Rizvi, A; Zaidi, AK1
Holla, P; Jameel, S; Munshi, SU; Panda, H; Rewari, BB1
Barthe, Y; Bouix, C; Cacoub, P; Carrat, F; Lascoux-Combe, C; Lebossé, F; Maynard-Muet, M; Miailhes, P; Piroth, L; Pol, S; Rey, D; Sogni, P; Zoulim, F1
Chang, JB; Chen, H; Cui, XQ; Dai, SX; Huang, JF; Liu, YJ; Luo, RH; Peng, YM; Wang, RR; Yang, QH; Zhang, XJ; Zheng, YT1
Bartlett, JA; Crump, JA; Grossmann, H; Masenga, EJ; Mavura, DR; Minja, E1
Back, DJ; Burger, D; Lamorde, M; Schapiro, JM1
Bader, J; Glass, TR; Klimkait, T; Labhardt, ND; Lejone, TI; Puga, D; Ringera, I1
He, C; Hsi, JH; Kan, W; Leng, X; Liao, L; Ruan, Y; Shao, Y; Wang, J; Xing, H1
Chim, B; Choun, K; Lorent, N; Lynen, L; Thai, S; van Griensven, J1
Cai, W; Caughey, B; Chung, C; Dai, Z; Hu, F; Lan, Y; Li, L; Tang, X; Zhang, K1
Amponsah-Dacosta, E; Blackard, JT; Gededzha, MP; Lukhwareni, A; Mphahlele, MJ; Rakgole, JN; Selabe, SG1
Belyhun, Y; Liebert, UG; Maier, M1
Belmonti, S; Borghetti, A; Cauda, R; De Luca, A; Di Giambenedetto, S; Fabbiani, M; Lombardi, F1
Borghetti, A; Castagna, A; Cauda, R; De Luca, A; Di Giambenedetto, S; Fabbiani, M; Galizzi, N; Gianotti, N; Gori, A; Maillard, M; Mondi, A; Poli, A1
Bessong, PO; Gachara, G; Kimbi, HK; Lum, E; Magoro, T; Mavhandu, L; Ndip, RN1
Brandão-Mello, CE; Brett-Smith, H; Cassetti, I; Gazzard, B; Hall, A; Huang, AK; Mendes-Corrêa, MC; Pessôa, MG; Phiri, P; Soriano, V1
Adams, E; Baert, L; Hoogmartens, J; Pendela, M; Rosier, J; Van den Mooter, G; Van Gyseghem, E1
Barreiro, P; García-Samaniego, J; Martín-Carbonero, L1
Barr, EA; Davies, JK; Forster-Harwood, J; Kinzie, K; Levin, MJ; McFarland, EJ; Pappas, J; Paul, SM; Salbenblatt, CR; Soda, E; Vazquez, A; Weinberg, A1
Evans, J; Jarrin, I; Lafuente-Lafuente, C; Mazeron, MC; Parrinello, M; Schnepf, N; Sellier, P; Simoneau, G1
Amuron, B; Birungi, J; Bunnell, R; Coutinho, A; Foster, S; Grosskurth, H; Jaffar, S; Kyomuhangi, R; Levin, J; Mermin, J; Nabiryo, C; Namara, G; Ndembi, N; Opio, A; Tappero, JW1
Airoldi, M; Cossarizza, A; De Biasi, S; Gibellini, L; Maggiolo, F; Mussini, C; Nasi, M; Pinti, M; Ravasio, V; Roat, E; Suter, F1
Corbett, AH; Hosseinipour, MC; Kanyama, C; Kashuba, AD; Kazembe, P; Mkupani, P; Mwansambo, C; Nyirenda, J; Rezk, NL; Sichali, D; Tien, H; Weigel, R1
Berg, CL; Coffin, CS; Curry, MP; Dove, LM; Nissen, NN; Ragni, M; Regenstein, FG; Roland, ME; Sherman, KE; Stock, PG; Terrault, NA1
Bachani, D; Chan, PL; Deshpande, A; Rajasekaran, S; Rewari, BB; Srikantiah, P1
Dhlomo, S; Emery, S; Grandits, G; Khabo, P; Khanyile, T; Komati, S; Magongoa, D; Naidoo, LC; Neaton, JD; Polis, M; Qolohle, D; Ratsela, A1
Amin, J; Cooper, DA; Cordery, DV; Hesse, K1
Biwolé-Sida, M; Bork, K; Coudray, M; Cournil, A; Delaporte, E; Essomba, CN; Kouanfack, C; Laurent, C; Tonfack, CA1
Nwankwo, N; Seker, H1
Ekwunife, OI; Iwuamadi, UI; Udeogaranya, OP; Ukwe, CV1
Chen, XY; Gui, X; Yang, RR; Zhu, Y1
Deng, L; Gao, S; Gui, X; Liang, K; Rong, Y; Xiong, Y; Yan, Y; Yang, R; Zhang, Y1
Rizzardini, G; Zucchi, P1
Dou, Z; Durako, S; Jiao, JH; Ma, Y; Xu, J; Yu, L; Zhang, F; Zhao, Y1
Budhathoki, C; Collier, AC; Daar, ES; Farajallah, A; Feinberg, J; Fischl, MA; Godfrey, C; Ha, B; Jahed, NC; Katzenstein, D; Mollan, K; Murphy, RL; Myers, L; Rooney, JF; Sax, PE; Tashima, K; Tierney, C; Woodward, WC1
Alvarez, Y; Hioe, CE; Nàdas, A; Tuen, M1
Branger, M; Collin, G; Fraqueiro, G; Gervais, A; Hamet, G; Lada, O; Marcellin, P; Martinot-Peignoux, M; Matheron, S; Moucari, R; Peytavin, G; Roquebert, B1
Aurpibul, L; Capparelli, E; Chokephaibulkit, K; Cressey, TR; Eksaengsri, A; Hongsiriwon, S; Kabat, B; Limwongse, C; McIntosh, K; Muresan, P; Ngampiyaskul, C; Sirisanthana, V; Smith, ME; Toye, M; Wittawatmongkol, O; Yogev, R1
Branger, M; Collin, G; Fraqueiro, G; Gervais, A; Lada, O; Leclerc, L; Marcellin, P; Martinot-Peignoux, M; Matheron, S; Moucari, R; Peytavin, G; Roquebert, B1
Aubron-Olivier, C; Calvez, V; Charpentier, C; Descamps, D; Katlama, C; Landman, R; Marcelin, AG; Simon, A; Valantin, MA; Wirden, M; Yeni, P1
Aguilar, C; Brown, RS; Buti, M; Fagan, EA; Leu, CS; Pereira, MR; Tilson, HH; Verna, EC1
Abel, F; Behrens, G; Domingo, P; Maserati, R; Pearce, G; Rieger, A; Wang, H1
Bonovas, S; Hatzakis, A; Nikolopoulos, G; Tsiodras, S1
Ananworanich, J; Bhakeecheep, S; Bowonwatanuwong, C; Bunupuradah, T; Chetchotisakd, P; Hirschel, B; Jirajariyavej, S; Kantipong, P; Kerr, SJ; Klinbuayaem, V; Munsakul, W; Prasithsirikul, W; Ruxrungtham, K; Sophonphan, J; Sungkanuparph, S1
Banerjee, A; Biswas, A; Chakrabarti, S; Chakravarty, R; Datta, S; Guha, SK; Pal, A; Panigrahi, R; Saha, B; Sarkar, N1
Armishaw, J; Cameron, PU; Chuah, J; Cooper, DA; Crowe, SM; Fairley, C; Gouillou, M; Hearps, A; Koelsch, KK; Leeansyah, E; Lewin, SR; Liu, JP; Pierce, AB; Smit, de V; Solomon, A; Spelman, T; Tennakoon, S; Velayudham, P1
Antinori, A; Bedini, A; Bertoli, A; Borghi, V; Bugarini, R; Cossarizza, A; D'Arrigo, R; Esposito, R; Mongiardo, N; Mussini, C; Perno, CF1
Adachi, M; Antonelli, G; Bambacioni, F; Focher, F; Riva, E; Sampath, J; Scagnolari, C; Schuetz, JD; Turriziani, O1
Livrozet, JM; Miossec, P; Touraine, JL; Wegrzyn, J1
Aboulker, JP; Brun-Vézinet, F; Descamps, D; Flandre, P; Harel, M; Izopet, J; Joly, V; Lastère, S; Meiffrédy, V; Peytavin, G; Tamalet, C; Yéni, P; Zeng, AF1
Khanna, N1
Camino, N; Núñez, M; Puoti, M; Soriano, V1
Pendergrass, S; Qazi, S; Uckun, FM; Venkatachalam, TK1
Benhamou, Y1
Ait-Khaled, M; Craig, C; Griffin, P; Stone, C; Tisdale, M1
Cohen, J2
Burchett, SK; Ciupak, G; Delke, I; Frenkel, L; Hitti, J; Huang, S; Mathias, A; Mofenson, L; Rathore, M; Samelson, R; Shapiro, DE; Smith, ME; Unadkat, JD; Wade, NA; Watts, DH; Yasin, S1
Aarnoutse, RE; Burger, DM; Verweij-van Wissen, CP1
Havlir, DV; Ignacio, CC; Koelsch, KK; Lu, B; Margot, N; Miller, MD; Strain, MC; Wong, JK1
Chan, KC; Lee, SS; Wong, KH1
Angel-Moreno-Maroto, A; Hernández-Cabrera, M; Pérez-Arellano, JL; Suárez-Castellano, L1
Thio, CL1
Arribas, JR; Campo, RE; Cheng, AK; Chuck, S; DeJesus, E; Enejosa, J; Gallant, JE; Gazzard, B; Lu, B; McColl, D; Pozniak, AL; Toole, JJ1
Jenny-Avital, ER1
Brown, J; Heffernan-Vacca, S; Millery, M; Neu, N; Stimell, M1
Farthing, C; Khanlou, H1
Andreotti, M; Ceffa, S; Cusato, M; Germano, P; Giuliano, M; Guidotti, G; Liotta, G; Loureiro, S; Mancini, MG; Marazzi, MC; Palombi, L; Pirillo, MF; Regazzi, M; Vella, S; Villani, P1
Aguilar, I; Hidalgo, A; Palacios, R; Santos, J1
Chow, DC; Khawcharoenporn, T; Shikuma, CM; Williams, AE1
Bendenoun, M; Mazeron, MC; Sanson-le Pors, MJ; Schnepf, N; Sellier, P; Zini, JM1
Dubé, MP; Grinspoon, SK; Komarow, L; Mulligan, K; Parker, RA; Robbins, GK; Roubenoff, R; Tebas, P1
Gulick, RM; Kuritzkes, DR; Ribaudo, HJ1
Acosta, EP; Bryson, Y; Capparelli, EV; Holland, D; Luzuriaga, K; Mirochnick, M; Patel, P; Tremoulet, AH; Wara, D; Zorrilla, C1
Asensi, V; Barreiro, P; de Mendoza, C; Estrada, V; González-Lahoz, J; Jiménez-Nacher, I; Palacios, R; Rivas, P; Rodríguez-Novoa, S; Sánchez-Conde, M; Santos, J; Sanz, J; Sola, J; Soriano, V1
Chen, J; Cooper, DA; Emery, S; Hazuda, DJ; Kelleher, AD; Law, M; Murray, JM; Nguyen, BY; Teppler, H1
Guillemi, S; Gutiérrez, S; Harrigan, PR; Jahnke, N; Montaner, JS; Montessori, V1
Asif, G; Hurwitz, SJ; Schinazi, RF1
Anglaret, X; Dabis, F; Dakoury-Dogbo, N; Diakite, N; Duvignac, J; Grundmann, C; Karcher, S; Kouadio, B; Marlink, R; Seyler, C; Toure, S; Traore, M1
Boucher, CA; Cammack, N; Hill, A; Ingrand, D; Loveday, C; Robert, C; Weber, J1
Bartlett, JA; Benoit, SL; Ehmann, WC; Fallon, MA; Johnson, VA; Quinn, JB; Rubin, M; Self, PL; Sepulveda, GE; Tsoukas, C1
Rowe, PM1
Bartlett, J; Eron, J; Gilbert, C; Hill, AM; Johnson, J; Johnson, VA; Keller, A; Kuritzkes, DR; Phillips, AN1
Ahle, D; Bushnell, S; Chang, C; Collins, ML; Detmer, J; Fine, E; Ho, DD; Horn, T; Irvine, B; Kolberg, J; Shen, LP; Tyner, D; Urdea, MS; Zayati, C1
Collins, DO; Sakamoto, A1
Crespo, J; Pons-Romero, F1
Adams, O; Horneff, G; Wahn, V1
Kaiser, R; Rockstroh, JK; Sauerbruch, T; Spengler, U; Theisen, A1
Balis, FM; Brouwers, P; Deutsch, PJ; Jarosinski, PF; Ju, W; Mistry, G; Mueller, BU; Nelson, RP; Pizzo, PA; Sei, S; Sleasman, J; Smith, S; Steinberg, SM; Winchell, G; Wood, LV; Zeichner, S; Zwerski, S1
Kibayashi, K; NG'walali, PM; Tsunenari, S1
de Jong, JJ; de Wolf, F; Foudraine, NA; Jan Weverling, G; Jurriaans, S; Keet, IP; Lange, JM; Maas, J; Roos, MT; van Benthem, BH; Vandermeulen, K1
Phillips, L1
Asensi, V; Carton, JA; Maradona, JA; Martínez, A; Rodríguez, M1
Aboulker, JP; Bazin, B; Brun-Vézinet, F; Calvez, V; Collin, G; Delaugerre, C; Descamps, D; Flandre, P; Meiffredy, V; Peytavin, G; Pialoux, G; Raffi, F; Robert-Delmas, S1
Collier, AC; Havlir, DV; Hellmann, NS; Hirsch, MS; Petropoulos, CJ; Richman, DD; Sommadossi, JP; Tebas, P; Whitcomb, JM1
Boschini, A; Calista, D1
Aladdin, H; Dickmeiss, E; Gerstoft, J; Hede, A; Jørgensen, LB; Katzenstein, TL; Nielsen, C; Nielsen, H1
Chodakewitz, JA; Condra, JH; Emini, EA; Eron, JJ; Gonzalez, C; Gulick, RM; Havlir, D; Isaacs, R; Jonas, L; McMahon, D; Meibohm, A; Mellors, JW; Richman, DD; Valentine, FT1
Atkinson, B; Isaacson, J; Knowles, M; Mazabel, E; Patick, AK1
Arnedo, A; Gómez, CJ; Roca, B1
Bechstein, WO; Berg, T; Hopf, U; Müller, AR; Neuhaus, P; Neuhaus, R; Rayes, N; Seehofer, D1
Bucy, RP; Gnann, JW; Goepfert, PA; Kilby, JM; Miller, AP; Saag, MS; Sillers, M1
Anderson, PL; Brundage, RC; Bushman, LR; Fletcher, CV; Kakuda, TN; Kawle, SP; Remmel, RP; Weller, D1
Giménez-Doménech, R; Kindelán, JM; Madueño, J; Vidal-Verdú, E1
Brotas, V; Cooper, D; Cutrell, A; Gathe, J; Hammer, SM; Hetherington, S; Hicks, C; Isaacs, R; Johnson, M; Keiser, P; Montaner, J; Raffi, F; Spreen, W; Staszewski, S; Steel, H; Thorborn, D; Tortell, S1
Jankelevich, S; Mackall, CL; Mueller, BU; Nelson, RP; Nguyen, BY; Pizzo, PA; Serchuck, L; Sleasman, JW; Smith, S; Steinberg, SM; Wood, LV; Yarchoan, R; Zeichner, SL; Zwerski, S1
Conant, M1
Mascolini, M1
Gilden, D1
Chang, HE1
Coombs, R; Cotton, D; Hammer, S; Saag, M; van der Horst, C1
Smart, T1
Torres, G1
Doepel, L; Folkers, G1
Woodward, J1
Delaney, WE; Locarnini, S; Shaw, T1
Bassett, R; Collier, AC; Condra, J; Gilbert, P; Günthard, HF; Havlir, DV; Hirsch, MS; Ignacio, C; Levitan, D; Richman, DD; Tebas, P; Wong, JK1
Bryant, ML; Cretton-Scott, E; Egron, D; el Kouni, MH; Faraj, A; Gosseli, G; Imbach, JL; Loi, AG; Martin, LT; Périgaud, C; Pierra, C; Placidi, L; Schinazi, RF; Sommadossi, JP1
Boyle, BA1
Boucher, CA; Cohen Stuart, JW; de Jong, D; Kaye, S; Kovacs, C; Righart, M; Schuurman, R; Visser, CJ; Wensing, AM1
Korn, K; Schmidt, B; Schwingel, E; Walter, H; Werwein, M1
Bartlett, JA; Bucy, RP; Fiscus, SA; Gryszowska, V; Miralles, GD; Ottinger, J; Pruitt, SK; Sevin, AD; Silberman, M1
Beltrami, EM; Cardo, DM; de la Torre, N; Luo, CC1
Cannon, D; Furman, PA; Lloyd, RM; Mathis, R; McMillan, A; Peck, A; Schinazi, RF; Sommadossi, JP; St Clair, M; Wilson, J1
Boehme, RE; Cameron, JM; Figueiredo, HT; Gray, NM; Hart, GJ; Orr, DC; Penn, CR1

Reviews

9 review(s) available for lamivudine and HIV

ArticleYear
Antivirals for prevention of hepatitis B virus mother-to-child transmission in human immunodeficiency virus positive pregnant women co-infected with hepatitis B virus.
    The Cochrane database of systematic reviews, 2023, 06-12, Volume: 6

    Topics: Antiviral Agents; Coinfection; DNA, Viral; Emtricitabine; Female; Hepatitis B e Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Lopinavir; Pregnancy; Pregnant Women; Ritonavir; Tenofovir; Zidovudine

2023
Comparative effectiveness of anti-viral drugs with dual activity for treating hepatitis B and HIV co-infected patients: a network meta-analysis.
    BMC infectious diseases, 2018, Nov-14, Volume: 18, Issue:1

    Topics: Adenine; Adult; Aged; Antiviral Agents; Coinfection; Emtricitabine; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Network Meta-Analysis; Organophosphonates; Tenofovir; Treatment Outcome; Young Adult

2018
Antiretroviral drugs for prevention of mother-to-child transmission: pharmacologic considerations for a public health approach.
    AIDS (London, England), 2014, Nov-13, Volume: 28, Issue:17

    Topics: Adenine; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Child; Cyclopropanes; Drug Resistance, Viral; Drug Therapy; HIV; HIV Infections; Humans; Infectious Disease Transmission, Vertical; Lamivudine; Organophosphonates; Public Health; Tenofovir

2014
[Hepatitis B in patients with HIV infection].
    Enfermedades infecciosas y microbiologia clinica, 2008, Volume: 26 Suppl 7

    Topics: Adenine; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Antiviral Agents; Comorbidity; Deoxycytidine; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Guanine; Hepatitis B; Hepatitis B Vaccines; Hepatitis B virus; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Nucleosides; Organophosphonates; Practice Guidelines as Topic; Pyrimidinones; Reverse Transcriptase Inhibitors; Telbivudine; Tenofovir; Thymidine; Virus Replication

2008
Abacavir and lamivudine for the treatment of human immunodeficiency virus.
    Expert opinion on pharmacotherapy, 2011, Volume: 12, Issue:13

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Clinical Trials, Phase III as Topic; Dideoxynucleosides; HIV; HIV Infections; Humans; Lamivudine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors

2011
Antiretrovirals for HIV Exposure Prophylaxis.
    Current medicinal chemistry, 2012, Volume: 19, Issue:35

    Topics: Adenine; Anti-HIV Agents; Deoxycytidine; Dideoxynucleosides; Emtricitabine; HIV; HIV Infections; Humans; Lamivudine; Occupational Exposure; Organophosphonates; Stavudine; Tenofovir; Zidovudine

2012
Didanosine, lamivudine-emtricitabine and efavirenz as initial therapy in naive patients.
    Expert review of anti-infective therapy, 2006, Volume: 4, Issue:6

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Deoxycytidine; Didanosine; Drug Resistance, Viral; Emtricitabine; HIV; HIV Infections; Humans; Lamivudine; Oxazines; Quality of Life; Reverse Transcriptase Inhibitors

2006
Recurrence of the acute HIV syndrome after interruption of antiretroviral therapy in a patient with chronic HIV infection: A case report.
    Annals of internal medicine, 2000, Sep-19, Volume: 133, Issue:6

    Topics: Acute Disease; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Chronic Disease; Disease Progression; Drug Therapy, Combination; Fever; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Recurrence; Reverse Transcriptase Inhibitors; RNA, Viral; Syndrome; Viral Load; Zidovudine

2000
Resistance of hepatitis B virus to antiviral drugs: current aspects and directions for future investigation.
    Antiviral chemistry & chemotherapy, 2001, Volume: 12, Issue:1

    Topics: 2-Aminopurine; Adenine; Amino Acid Sequence; Animals; Anti-HIV Agents; Antimetabolites; Antiviral Agents; Biological Availability; Cell Line; Clinical Trials as Topic; DNA Replication; DNA-Directed DNA Polymerase; DNA, Viral; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Viral; Drug Therapy, Combination; Enzyme Inhibitors; Famciclovir; Gene Products, pol; Hepatitis B; Hepatitis B virus; Hepatitis Viruses; Hepatitis, Animal; HIV; Humans; Lamivudine; Models, Animal; Molecular Sequence Data; Molecular Structure; Nucleosides; Organophosphonates; Sequence Alignment; Sequence Homology, Amino Acid; Species Specificity; Virus Replication

2001

Trials

36 trial(s) available for lamivudine and HIV

ArticleYear
Population pharmacokinetics of abacavir and lamivudine in severely malnourished human immunodeficiency virus-infected children in relation to treatment outcomes.
    British journal of clinical pharmacology, 2019, Volume: 85, Issue:9

    Topics: Anti-HIV Agents; Biological Availability; Body Weight; Child; Child Nutrition Disorders; Child, Preschool; Dideoxynucleosides; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Dosage Calculations; Female; Follow-Up Studies; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Models, Biological; Nutritional Support; Severity of Illness Index; South Africa; Time Factors; Time-to-Treatment; Treatment Outcome; Viral Load

2019
Role of a 48-week pegylated interferon therapy in hepatitis B e antigen positive HIV-co-infected patients on cART including tenofovir: EMVIPEG study.
    Journal of hepatology, 2014, Volume: 61, Issue:4

    Topics: Adenine; Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; CD4 Lymphocyte Count; Coinfection; Deoxycytidine; Drug Carriers; Emtricitabine; Female; Hepatitis B e Antigens; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Male; Middle Aged; Organophosphonates; Polyethylene Glycols; Recombinant Proteins; Tenofovir; Treatment Outcome; Viral Load

2014
Efficacy and safety of entecavir for chronic HBV in HIV/HBV coinfected patients receiving lamivudine as part of antiretroviral therapy.
    AIDS (London, England), 2008, Sep-12, Volume: 22, Issue:14

    Topics: Adult; Antiretroviral Therapy, Highly Active; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Female; Follow-Up Studies; Guanine; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Linear Models; Male; Middle Aged; Single-Blind Method; Virus Replication

2008
Rates of virological failure in patients treated in a home-based versus a facility-based HIV-care model in Jinja, southeast Uganda: a cluster-randomised equivalence trial.
    Lancet (London, England), 2009, Dec-19, Volume: 374, Issue:9707

    Topics: Adenine; Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Community Health Services; Female; HIV; HIV Infections; Home Care Services; Humans; Lamivudine; Male; Nevirapine; Organophosphonates; Stavudine; Tenofovir; Uganda; Zidovudine

2009
Mitochondrial changes during D-drug-containing once-daily therapy in HIV-positive treatment-naive patients.
    Antiviral therapy, 2010, Volume: 15, Issue:1

    Topics: Adenine; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cross-Sectional Studies; Cyclopropanes; Didanosine; Dideoxynucleosides; DNA, Mitochondrial; Drug Administration Schedule; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; RNA; RNA, Mitochondrial; Tenofovir

2010
Pharmacokinetics of generic and trade formulations of lamivudine, stavudine and nevirapine in HIV-infected Malawian children.
    Antiviral therapy, 2010, Volume: 15, Issue:1

    Topics: Adolescent; Anti-HIV Agents; Body Weight; Child; Child, Preschool; Cross-Over Studies; Dosage Forms; Drug Administration Schedule; Drugs, Generic; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Malawi; Male; Nevirapine; Prospective Studies; Stavudine

2010
A randomized factorial trial comparing 4 treatment regimens in treatment-naive HIV-infected persons with AIDS and/or a CD4 cell count <200 cells/μL in South Africa.
    The Journal of infectious diseases, 2010, Nov-15, Volume: 202, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; Humans; Lamivudine; Lopinavir; Male; Pyrimidinones; Ritonavir; RNA, Viral; South Africa; Stavudine; Treatment Outcome; Zidovudine

2010
Abacavir/lamivudine versus tenofovir DF/emtricitabine as part of combination regimens for initial treatment of HIV: final results.
    The Journal of infectious diseases, 2011, Oct-15, Volume: 204, Issue:8

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Deoxycytidine; Dideoxynucleosides; Double-Blind Method; Emtricitabine; Female; HIV; HIV Infections; Humans; Kaplan-Meier Estimate; Lamivudine; Male; Middle Aged; Organophosphonates; RNA, Viral; Tenofovir; Viral Load

2011
Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected children.
    Antiviral therapy, 2011, Volume: 16, Issue:8

    Topics: Anti-HIV Agents; Area Under Curve; Aryl Hydrocarbon Hydroxylases; Biological Availability; Body Weight; Child; Child, Preschool; Cytochrome P-450 CYP2B6; Drug Administration Schedule; Drug Combinations; Drug Dosage Calculations; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Oxidoreductases, N-Demethylating; Reverse Transcriptase Inhibitors; Tablets; Zidovudine

2011
Switching to tenofovir/emtricitabine from abacavir/lamivudine in HIV-infected adults with raised cholesterol: effect on lipid profiles.
    Antiviral therapy, 2012, Volume: 17, Issue:6

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cholesterol; Deoxycytidine; Dideoxynucleosides; Drug Combinations; Drug Substitution; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; Female; HIV; HIV Infections; Humans; Lamivudine; Lipids; Lopinavir; Male; Medication Adherence; Middle Aged; Organophosphorus Compounds; Ritonavir; Treatment Outcome

2012
A randomized comparison of second-line lopinavir/ritonavir monotherapy versus tenofovir/lamivudine/lopinavir/ritonavir in patients failing NNRTI regimens: the HIV STAR study.
    Antiviral therapy, 2012, Volume: 17, Issue:7

    Topics: Adenine; Adult; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lopinavir; Male; Organophosphonates; Ritonavir; Tenofovir

2012
Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500 cells/microl.
    AIDS (London, England), 2002, Jul-26, Volume: 16, Issue:11

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Female; Genotype; HIV; HIV Infections; Humans; Lamivudine; Male; Mutation; RNA, Viral; Time Factors; Viral Load

2002
Effect of zidovudine resistance mutations on virologic response to treatment with zidovudine or stavudine, each in combination with lamivudine and indinavir.
    Journal of acquired immune deficiency syndromes (1999), 2002, Dec-15, Volume: 31, Issue:5

    Topics: Anti-HIV Agents; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Male; Mutation; Patient Compliance; RNA, Viral; Stavudine; Viral Load; Zidovudine

2002
Pharmacokinetics and safety of stavudine in HIV-infected pregnant women and their infants: Pediatric AIDS Clinical Trials Group protocol 332.
    The Journal of infectious diseases, 2004, Dec-15, Volume: 190, Issue:12

    Topics: Adult; Amniotic Fluid; Anti-HIV Agents; Area Under Curve; Drug Therapy, Combination; Female; Half-Life; HIV; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Metabolic Clearance Rate; Pregnancy; Pregnancy Complications, Infectious; Stavudine; Viral Load

2004
Tenofovir DF, emtricitabine, and efavirenz vs. zidovudine, lamivudine, and efavirenz for HIV.
    The New England journal of medicine, 2006, Jan-19, Volume: 354, Issue:3

    Topics: Adenine; Adolescent; Adult; Aged; Alkynes; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Deoxycytidine; Emtricitabine; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Organophosphonates; Oxazines; Prospective Studies; RNA, Viral; Tenofovir; Zidovudine

2006
Postexposure prophylaxis for HIV in children and adolescents after sexual assault: a prospective observational study in an urban medical center.
    Sexually transmitted diseases, 2007, Volume: 34, Issue:2

    Topics: Adolescent; Adult; Anti-HIV Agents; Child; Drug Combinations; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; New York City; Patient Compliance; Prospective Studies; Regression Analysis; Sex Offenses; Zidovudine

2007
Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program.
    Journal of acquired immune deficiency syndromes (1999), 2007, Mar-01, Volume: 44, Issue:3

    Topics: Adolescent; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Female; HIV; HIV Infections; Humans; Lamivudine; Milk, Human; Nevirapine; Pilot Projects; Pregnancy; Pregnancy Complications, Infectious; Pregnancy Trimester, Third; RNA, Viral; Stavudine; Zidovudine

2007
Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of Adult Clinical Trials Group 384.
    Journal of acquired immune deficiency syndromes (1999), 2007, Aug-15, Volume: 45, Issue:5

    Topics: Absorptiometry, Photon; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Body Composition; Cyclopropanes; Didanosine; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; HIV-Associated Lipodystrophy Syndrome; Humans; Lamivudine; Male; Middle Aged; Nelfinavir; Prospective Studies; Stavudine; Time Factors; Treatment Outcome; United States; Zidovudine

2007
A comparison of three initial antiretroviral AIDS regimens.
    The New England journal of medicine, 2007, Sep-06, Volume: 357, Issue:10

    Topics: Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; HIV; HIV Infections; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine

2007
Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phase.
    AIDS (London, England), 2007, Nov-12, Volume: 21, Issue:17

    Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Administration Schedule; Drug Therapy, Combination; HIV; HIV Infections; HIV Integrase Inhibitors; Humans; Lamivudine; Linear Models; Organic Chemicals; Organophosphonates; Pyrrolidinones; Raltegravir Potassium; RNA, Viral; Statistics, Nonparametric; Tenofovir; Time Factors; Viral Load; Virus Integration; Virus Latency; Virus Replication

2007
Phase I/II study of 3TC (lamivudine) in HIV-positive, asymptomatic or mild AIDS-related complex patients: sustained reduction in viral markers. The Lamivudine European HIV Working Group.
    AIDS (London, England), 1995, Volume: 9, Issue:12

    Topics: Adult; AIDS-Related Complex; Antigen-Antibody Complex; Antiviral Agents; Dose-Response Relationship, Drug; HIV; HIV Core Protein p24; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; Viremia; Zalcitabine

1995
Lamivudine plus zidovudine compared with zalcitabine plus zidovudine in patients with HIV infection. A randomized, double-blind, placebo-controlled trial. North American HIV Working Party.
    Annals of internal medicine, 1996, Aug-01, Volume: 125, Issue:3

    Topics: Adult; Antiviral Agents; beta 2-Microglobulin; Biopterins; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Female; HIV; HIV Core Protein p24; HIV Infections; Humans; Lamivudine; Male; Neopterin; Polymerase Chain Reaction; RNA, Viral; Severity of Illness Index; Time Factors; Treatment Outcome; Zalcitabine; Zidovudine

1996
Pilot study of zidovudine-lamivudine combination therapy in vertically HIV-infected antiretroviral-naive children.
    AIDS (London, England), 1998, Mar-26, Volume: 12, Issue:5

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; HIV; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Lamivudine; Male; Pilot Projects; RNA, Viral; Viral Load; Zidovudine

1998
A phase I/II study of the protease inhibitor indinavir in children with HIV infection.
    Pediatrics, 1998, Volume: 102, Issue:1 Pt 1

    Topics: Adolescent; Adult; Biological Availability; Capsules; CD4 Lymphocyte Count; Child; Child, Preschool; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infant; Lamivudine; Male; Suspensions; Viral Load; Virus Replication; Zidovudine

1998
An open randomized controlled trial of zidovudine plus lamivudine versus stavudine plus lamivudine.
    AIDS (London, England), 1998, Aug-20, Volume: 12, Issue:12

    Topics: Adult; CD4 Lymphocyte Count; CD8-Positive T-Lymphocytes; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Homosexuality, Male; Humans; Indinavir; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Stavudine; Treatment Outcome; Viral Load; Zidovudine

1998
Lamivudine for chronic hepatitis B and HIV co-infection.
    AIDS (London, England), 1999, May-28, Volume: 13, Issue:8

    Topics: Adult; Anti-HIV Agents; Antiviral Agents; DNA, Viral; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Reverse Transcriptase Inhibitors; RNA, Viral

1999
Mechanisms of virologic failure in previously untreated HIV-infected patients from a trial of induction-maintenance therapy. Trilège (Agence Nationale de Recherches sur le SIDA 072) Study Team).
    JAMA, 2000, Jan-12, Volume: 283, Issue:2

    Topics: Anti-HIV Agents; Case-Control Studies; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Patient Compliance; Treatment Failure; Viral Load; Zidovudine

2000
3-year suppression of HIV viremia with indinavir, zidovudine, and lamivudine.
    Annals of internal medicine, 2000, Jul-04, Volume: 133, Issue:1

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Genotype; HIV; HIV Infections; Humans; Indinavir; Kidney Calculi; Lamivudine; Male; Middle Aged; RNA, Viral; Viral Load; Viremia; Zidovudine

2000
Lamivudine as first- and second-line treatment of hepatitis B infection after liver transplantation.
    Transplant international : official journal of the European Society for Organ Transplantation, 2000, Volume: 13, Issue:4

    Topics: 2-Aminopurine; Anti-HIV Agents; Antiviral Agents; Famciclovir; Hepatitis B; Hepatitis B virus; HIV; Humans; Lamivudine; Liver; Liver Transplantation; Prospective Studies; Reverse Transcriptase Inhibitors

2000
Zidovudine triphosphate and lamivudine triphosphate concentration-response relationships in HIV-infected persons.
    AIDS (London, England), 2000, Sep-29, Volume: 14, Issue:14

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cytidine Triphosphate; Dideoxynucleotides; Dose-Response Relationship, Drug; Drug Therapy, Combination; HIV; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Middle Aged; Prospective Studies; Regression Analysis; Reverse Transcriptase Inhibitors; RNA, Viral; Thymine Nucleotides; Zidovudine

2000
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults: A randomized equivalence trial.
    JAMA, 2001, Mar-07, Volume: 285, Issue:9

    Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Dideoxynucleosides; Double-Blind Method; Drug Resistance, Microbial; Female; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; HIV Reverse Transcriptase; Humans; Indinavir; Lamivudine; Male; Middle Aged; Mutation; Reverse Transcriptase Inhibitors; Survival Analysis; Therapeutic Equivalency; Viral Load; Zidovudine

2001
Long-term virologic and immunologic responses in human immunodeficiency virus type 1-infected children treated with indinavir, zidovudine, and lamivudine.
    The Journal of infectious diseases, 2001, Apr-01, Volume: 183, Issue:7

    Topics: Adolescent; Anti-HIV Agents; CD4 Antigens; CD4 Lymphocyte Count; Child; Child, Preschool; Drug Therapy, Combination; Female; Follow-Up Studies; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Leukocyte Common Antigens; Male; Protein Tyrosine Phosphatase, Non-Receptor Type 1; RNA, Viral; Viral Load; Zidovudine

2001
Combination shows reduction in viral levels.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:3

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; HIV Seropositivity; Humans; Indinavir; Lamivudine; Time Factors; Zidovudine

1996
Drug combination shows benefits for AIDS patients with history of taking AZT.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; Follow-Up Studies; HIV; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Time Factors; Zidovudine

1996
Phase II/III Trials of Viracept start.
    AIDS patient care and STDs, 1996, Volume: 10, Issue:3

    Topics: Anti-HIV Agents; Blood; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Isoquinolines; Lamivudine; Nelfinavir; Pilot Projects; Reverse Transcriptase Inhibitors; Stavudine; Sulfonic Acids; Time Factors; Zidovudine

1996
Addition of cyclophosphamide to antiretroviral therapy does not diminish the cellular reservoir in HIV-infected persons.
    AIDS research and human retroviruses, 2002, May-20, Volume: 18, Issue:8

    Topics: Adolescent; Adult; CD4 Lymphocyte Count; Cyclophosphamide; DNA, Viral; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Lymphoid Tissue; Male; Middle Aged; Monocytes; Nelfinavir; Pilot Projects; Reverse Transcriptase Inhibitors; RNA, Viral; Stavudine; Viral Load

2002

Other Studies

115 other study(ies) available for lamivudine and HIV

ArticleYear
Synthesis, anti-human immunodeficiency virus and anti-hepatitis B virus activities of novel oxaselenolane nucleosides.
    Journal of medicinal chemistry, 1997, Sep-12, Volume: 40, Issue:19

    Topics: Anti-HIV Agents; Antiviral Agents; Cytosine; Flucytosine; Hepatitis B virus; HIV; Humans; Indicators and Reagents; Molecular Conformation; Molecular Structure; Nucleosides; Structure-Activity Relationship

1997
Synthesis and biological evaluation of a series of 2'-fluorinated-2',3'-dideoxy-2',3'-didehydro-(L)-nucleosides.
    Bioorganic & medicinal chemistry letters, 1998, Jul-07, Volume: 8, Issue:13

    Topics: Antiviral Agents; Cell Line; Dideoxynucleosides; Fluorine; Hepatitis B virus; HIV; Humans

1998
Isolation and biological evaluation of filiformin, plakortide F, and plakortone G from the Caribbean sponge Plakortis sp.
    Journal of natural products, 2001, Volume: 64, Issue:11

    Topics: Animals; Antimalarials; Bromobenzenes; Chromatography, High Pressure Liquid; Colonic Neoplasms; Dioxanes; Gas Chromatography-Mass Spectrometry; Hepatitis B; HIV; Humans; Jamaica; Lactones; Leukemia P388; Lung Neoplasms; Mice; Molecular Structure; Mycobacterium tuberculosis; Neoplasms, Unknown Primary; Nuclear Magnetic Resonance, Biomolecular; Plasmodium berghei; Plasmodium falciparum; Porifera; Spectrometry, Mass, Electrospray Ionization; Tumor Cells, Cultured

2001
Synthesis and antiviral activity of helioxanthin analogues.
    Journal of medicinal chemistry, 2005, Jan-27, Volume: 48, Issue:2

    Topics: Antiviral Agents; Benzofurans; Cytomegalovirus; Dioxoles; Hepacivirus; Hepatitis B virus; Herpesvirus 1, Human; Herpesvirus 2, Human; Herpesvirus 4, Human; HIV; Lactones; Lignans; Naphthalenes; Structure-Activity Relationship

2005
Indazolyl-substituted piperidin-4-yl-aminopyrimidines as HIV-1 NNRTIs: Design, synthesis and biological activities.
    European journal of medicinal chemistry, 2020, Jan-15, Volume: 186

    Topics: Anti-HIV Agents; Dose-Response Relationship, Drug; Drug Design; HIV; HIV Reverse Transcriptase; Humans; Indazoles; Microbial Sensitivity Tests; Molecular Structure; Piperidines; Pyrimidines; Reverse Transcriptase Inhibitors; Structure-Activity Relationship

2020
Rapid simultaneous analysis of anti human immunodeficiency virus drugs in pharmaceutical formulation by smart spectrophotometry based on multivariate calibration and least squares support vector machine methods.
    Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy, 2023, Apr-05, Volume: 290

    Topics: Calibration; Drug Compounding; HIV; Lamivudine; Least-Squares Analysis; Spectrophotometry; Support Vector Machine; Zidovudine

2023
Incidence and factors associated with hepatitis B surface antigen seroclearance in patients co-infected with HBV/HIV during antiretroviral therapy in Guangdong, China.
    Chinese medical journal, 2023, Nov-20, Volume: 136, Issue:22

    Topics: Adult; Coinfection; DNA, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Incidence; Lamivudine; Male; Retrospective Studies; Tenofovir

2023
Cryptococcal meningitis and immune reconstitution inflammatory syndrome in a pediatric patient with HIV after switching to second line antiretroviral therapy: a case report.
    BMC infectious diseases, 2020, Jan-21, Volume: 20, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Alkynes; Anti-HIV Agents; Antifungal Agents; Antigens, Fungal; Benzoxazines; Child; Cryptococcus neoformans; Cyclopropanes; Dideoxynucleosides; Drug Combinations; Female; Fluconazole; HIV; Humans; Immune Reconstitution Inflammatory Syndrome; Lamivudine; Lopinavir; Meningitis, Cryptococcal; Ritonavir; Treatment Outcome; Viral Load; Zidovudine

2020
Lamivudine-resistant HIV
    Journal of global antimicrobial resistance, 2020, Volume: 20

    Topics: Administration, Oral; Animals; Disease Models, Animal; Drug Combinations; Heterocyclic Compounds, 3-Ring; HIV; HIV Infections; Humans; Lamivudine; Mice; Mutation; Oxazines; Piperazines; Pyridones; Treatment Outcome

2020
Case report: one case of coronavirus disease 2019 (COVID-19) in a patient co-infected by HIV with a normal CD4
    AIDS research and therapy, 2020, 07-23, Volume: 17, Issue:1

    Topics: Alkynes; Anti-Retroviral Agents; Benzoxazines; Betacoronavirus; C-Reactive Protein; CD4 Lymphocyte Count; Chills; Coronavirus Infections; COVID-19; Cyclopropanes; Fatigue; Female; Fever; HIV; HIV Infections; Humans; Immunocompromised Host; Immunoglobulin M; Lamivudine; Middle Aged; Pandemics; Pharyngitis; Pneumonia, Viral; Real-Time Polymerase Chain Reaction; SARS-CoV-2; Sputum; Time Factors; Tomography, X-Ray Computed; Virus Shedding; Zidovudine

2020
Comparison of HIV-DNA decay in naive patients starting dolutegravir plus lamivudine or dolutegravir-based triple therapy.
    Le infezioni in medicina, 2020, Sep-01, Volume: 28, Issue:3

    Topics: Adult; Anti-HIV Agents; DNA; Drug Combinations; Female; Heterocyclic Compounds, 3-Ring; HIV; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Middle Aged; Oxazines; Piperazines; Prospective Studies; Pyridones

2020
Evolution of blood lipids and risk factors of dyslipidemia among people living with human immunodeficiency virus who had received first-line antiretroviral regimens for 3 years in Shenzhen.
    Chinese medical journal, 2020, Dec-05, Volume: 133, Issue:23

    Topics: Aged; Anti-HIV Agents; China; Dyslipidemias; HIV; HIV Infections; Humans; Lamivudine; Lipids; Risk Factors

2020
Prevalence and evaluation of risk factors of anti-retroviral therapy failure among human immunodeficiency virus/acquired immune deficiency syndrome patients in North India.
    Transactions of the Royal Society of Tropical Medicine and Hygiene, 2021, 09-03, Volume: 115, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; CD4 Lymphocyte Count; HIV; HIV Infections; Humans; India; Lamivudine; Male; Prevalence; Risk Factors; Viral Load; Zidovudine

2021
A retrospective case-cohort study comparing treatment outcomes in abacavir versus stavudine containing first line antiretroviral treatment regimens in children <3yrs old, at a paediatric programme based in Soweto, South Africa.
    PloS one, 2017, Volume: 12, Issue:7

    Topics: Child, Preschool; Dideoxynucleosides; Drug Combinations; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Lopinavir; Male; Retrospective Studies; Ritonavir; South Africa; Stavudine; Treatment Outcome; Viral Load

2017
Lamivudine monotherapy in children and adolescents: The devil is in the detail.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2017, Nov-27, Volume: 107, Issue:12

    Topics: Adolescent; Anti-HIV Agents; Child; Disease Management; Drug Monitoring; Drug Resistance, Viral; Genes, Viral; HIV; HIV Infections; Humans; Lamivudine; Long-Term Care; Medication Adherence; Mutation; Viral Load

2017
First reported case of integrase (R263K, G163R) and reverse transcriptase (M184V)-transmitted drug resistance from a drug-naive patient failing Triumeq.
    AIDS (London, England), 2018, 08-24, Volume: 32, Issue:13

    Topics: Adult; Anti-HIV Agents; Dideoxynucleosides; Drug Combinations; Drug Resistance, Viral; Female; Heterocyclic Compounds, 3-Ring; HIV; HIV Infections; HIV Integrase; HIV Reverse Transcriptase; Humans; Lamivudine; Mutation, Missense; Treatment Failure

2018
Compromise of Second-Line Antiretroviral Therapy Due to High Rates of Human Immunodeficiency Virus Drug Resistance in Mozambican Treatment-Experienced Children With Virologic Failure.
    Journal of the Pediatric Infectious Diseases Society, 2020, Feb-28, Volume: 9, Issue:1

    Topics: Adolescent; Anti-Retroviral Agents; Child; Child, Preschool; Cross-Sectional Studies; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Mozambique; Nevirapine; Stavudine; Treatment Failure; Viral Load

2020
High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
    Intervirology, 2018, Volume: 61, Issue:3

    Topics: Adult; Anti-HIV Agents; China; Coinfection; DNA-Directed DNA Polymerase; Drug Resistance, Multiple, Viral; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Multivariate Analysis; Mutation; Prevalence; Tenofovir; Viral Load

2018
Adherence, virological outcome, and drug resistance in Chinese HIV patients receiving first-line antiretroviral therapy from 2011 to 2015.
    Medicine, 2018, Volume: 97, Issue:50

    Topics: Adult; Anti-HIV Agents; China; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Medication Adherence; Middle Aged; Retrospective Studies; Stavudine; Sustained Virologic Response; Tenofovir; Zidovudine

2018
Antiretroviral Monotherapy for HIV: Game Over or Future Perspectives?
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2019, 10-15, Volume: 69, Issue:9

    Topics: Dideoxynucleosides; Heterocyclic Compounds, 3-Ring; HIV; HIV Infections; Humans; Lamivudine; Oxazines; Piperazines; Pyridones

2019
Letter to the editor: switching treatment to lamivudine plus boosted atazanavir or darunavir in virologically suppressed HIV-infected patients - evidence from a large observational cohort.
    Infectious diseases (London, England), 2019, Volume: 51, Issue:3

    Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; Darunavir; HIV; HIV Infections; Humans; Lamivudine; Ritonavir

2019
Development and validation of a stability indicating method for seven novel derivatives of lamivudine with anti-HIV and anti-HBV activity in simulated gastric and intestinal fluids.
    Journal of pharmaceutical and biomedical analysis, 2013, May-05, Volume: 78-79

    Topics: Antiviral Agents; Chromatography, High Pressure Liquid; Hepatitis B virus; HIV; Humans; Lamivudine; Limit of Detection; Reproducibility of Results; Reverse Transcriptase Inhibitors

2013
Cardiometabolic risk factors among HIV patients on antiretroviral therapy.
    Lipids in health and disease, 2013, Apr-10, Volume: 12

    Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cyclopropanes; Female; HIV; HIV Infections; Humans; Insulin Resistance; Lamivudine; Male; Middle Aged; Nevirapine; Organophosphonates; Risk Factors; Stavudine; Tenofovir; Triglycerides; Zambia; Zidovudine

2013
Clinical manifestations and treatment outcomes in HIV-1-infected children receiving antiretroviral therapy in Karachi, Pakistan.
    Journal of infection in developing countries, 2014, Apr-15, Volume: 8, Issue:4

    Topics: Anti-HIV Agents; Body Height; Body Weight; CD4 Lymphocyte Count; Child, Preschool; Drug Resistance, Viral; Female; Genotype; HIV; HIV Infections; Humans; Infant; Lamivudine; Male; Nevirapine; Pakistan; Retrospective Studies; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load; Zidovudine

2014
MicroRNA-150 is a potential biomarker of HIV/AIDS disease progression and therapy.
    PloS one, 2014, Volume: 9, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; CD4 Lymphocyte Count; Cyclopropanes; Disease Progression; Drug Resistance, Viral; Female; Gene Expression Regulation; HIV; Humans; Lamivudine; Leukocytes, Mononuclear; Male; MicroRNAs; Nevirapine; Stavudine; Treatment Outcome; Viral Load; Zidovudine

2014
Azvudine, a novel nucleoside reverse transcriptase inhibitor showed good drug combination features and better inhibition on drug-resistant strains than lamivudine in vitro.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Anti-HIV Agents; Azides; Cell Line; Deoxycytidine; Drug Resistance, Viral; Genotype; HIV; HIV Reverse Transcriptase; Humans; Lamivudine; Microbial Sensitivity Tests; Models, Molecular; Molecular Conformation; Protein Binding; Reverse Transcriptase Inhibitors; Virus Replication

2014
Initiation of antiretroviral therapy in HIV-infected adults with skin complaints in northern Tanzania.
    International journal of dermatology, 2015, Volume: 54, Issue:1

    Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Nevirapine; Prospective Studies; RNA, Viral; Severity of Illness Index; Skin Diseases; Stavudine; Tanzania; Young Adult

2015
Is zidovudine first-line therapy virologically comparable to tenofovir in resource-limited settings?
    Tropical medicine & international health : TM & IH, 2015, Volume: 20, Issue:7

    Topics: Adenine; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cross-Sectional Studies; Cyclopropanes; Female; Health Resources; HIV; HIV Infections; Humans; Lamivudine; Lesotho; Logistic Models; Male; Middle Aged; Organophosphonates; Tenofovir; Viral Load; Zidovudine

2015
Reductions in virological failure and drug resistance in Chinese antiretroviral-treated patients due to lamivudine-based regimens, 2003-12.
    The Journal of antimicrobial chemotherapy, 2015, Volume: 70, Issue:7

    Topics: Adult; Anti-Retroviral Agents; China; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Incidence; Lamivudine; Male; Medication Adherence; Treatment Failure

2015
Implementation of isoniazid preventive therapy in an HIV clinic in Cambodia: high rates of discontinuation when combined with antiretroviral therapy.
    Tropical medicine & international health : TM & IH, 2015, Volume: 20, Issue:12

    Topics: Adult; Ambulatory Care Facilities; Anti-HIV Agents; Antitubercular Agents; Cambodia; Drug Interactions; Female; HIV; HIV Infections; Humans; Isoniazid; Lamivudine; Male; Nevirapine; Opportunistic Infections; Patient Dropouts; Retrospective Studies; Stavudine; Tuberculosis

2015
Plasma Mitochondrial DNA Levels as a Biomarker of Lipodystrophy Among HIV-infected Patients Treated with Highly Active Antiretroviral Therapy (HAART).
    Current molecular medicine, 2015, Volume: 15, Issue:10

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Biomarkers; Case-Control Studies; Cyclopropanes; DNA, Mitochondrial; Drug Combinations; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Lopinavir; Male; Middle Aged; Mitochondria; Nelfinavir; Predictive Value of Tests; Ritonavir; ROC Curve; Stavudine; Zidovudine

2015
Evidence of susceptibility to lamivudine-based HAART and genetic stability of hepatitis B virus (HBV) in HIV co-infected patients: A South African longitudinal HBV whole genome study.
    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases, 2016, Volume: 43

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Coinfection; DNA, Viral; Evolution, Molecular; Female; Genome, Viral; Genotype; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Male; Microbial Sensitivity Tests; Middle Aged; Retrospective Studies; South Africa; Viral Load

2016
HIV therapy with unknown HBV status is responsible for higher rate of HBV genome variability in Ethiopia.
    Antiviral therapy, 2017, Volume: 22, Issue:2

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; Coinfection; Cyclopropanes; DNA, Viral; Drug Resistance, Viral; Ethiopia; Female; Genetic Variation; Genome, Viral; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Immune Evasion; Lamivudine; Male; Mutation; Stavudine; Viral Load; Zidovudine

2017
Impact of 48 weeks of atazanavir/ritonavir plus lamivudine dual therapy on cellular HIV-DNA levels in the AtLaS pilot study.
    The Journal of antimicrobial chemotherapy, 2016, Volume: 71, Issue:12

    Topics: Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; DNA, Viral; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Leukocytes, Mononuclear; Pilot Projects; Polymerase Chain Reaction; Ritonavir

2016
Simplification to a dual regimen with darunavir/ritonavir plus lamivudine or emtricitabine in virologically-suppressed HIV-infected patients.
    The Journal of infection, 2016, Volume: 73, Issue:6

    Topics: Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Cyclopropanes; Darunavir; Emtricitabine; HIV; Humans; Lamivudine; Ritonavir; Tenofovir; United Kingdom

2016
Characterization of occult hepatitis B virus infection among HIV positive patients in Cameroon.
    AIDS research and therapy, 2017, Mar-08, Volume: 14, Issue:1

    Topics: Adolescent; Adult; Base Sequence; Cameroon; Child, Preschool; Coinfection; Cross-Sectional Studies; DNA, Viral; Drug Resistance, Viral; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B Core Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Infections; HIV Seropositivity; Humans; Lamivudine; Male; Middle Aged; Mutation; Phylogeny; Prevalence; Prospective Studies; Risk Factors; Sequence Analysis; Young Adult

2017
Development of a liquid chromatographic assay for an anti-HIV tablet containing lamivudine, zidovudine and TMC278.HCL.
    Journal of pharmaceutical and biomedical analysis, 2009, Feb-20, Volume: 49, Issue:2

    Topics: Anti-HIV Agents; Biological Assay; Calibration; Chemistry, Pharmaceutical; Chromatography, Liquid; HIV; Humans; Lamivudine; Light; Molecular Structure; Nitriles; Pyrimidines; Reference Standards; Rilpivirine; Scattering, Radiation; Sensitivity and Specificity; Solvents; Spectrophotometry, Ultraviolet; Tablets; Zidovudine

2009
Resistance to antiretrovirals in HIV-infected pregnant women.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2009, Volume: 45, Issue:1

    Topics: Adult; Anti-HIV Agents; Data Interpretation, Statistical; Drug Resistance, Viral; Female; HIV; HIV Infections; Humans; Infant, Newborn; Infectious Disease Transmission, Vertical; Lamivudine; Mutation; Pregnancy; Pregnancy Complications, Infectious; Retrospective Studies; Viral Load; Zidovudine

2009
Truvada and Epivir are similar at suppressing HIV.
    Project Inform perspective, 2009, Issue:48

    Topics: CD4 Lymphocyte Count; Deoxycytidine; Drug Combinations; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination; HIV; HIV Infections; Humans; Lamivudine; Organophosphorus Compounds; Viral Load

2009
Description of liver disease in a cohort of HIV/HBV coinfected patients.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2010, Volume: 47, Issue:1

    Topics: Adult; Alanine Transaminase; Analysis of Variance; Anti-HIV Agents; Aspartate Aminotransferases; Cohort Studies; DNA, Viral; Female; Hepatitis B; HIV; HIV Infections; Humans; Lamivudine; Male; Predictive Value of Tests; Proportional Hazards Models; Risk Factors; Statistics, Nonparametric

2010
Virologic and clinical outcomes of hepatitis B virus infection in HIV-HBV coinfected transplant recipients.
    American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons, 2010, Volume: 10, Issue:5

    Topics: Adult; Aged; Antiviral Agents; Graft Survival; Hepatitis; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Immunoglobulins; Immunologic Deficiency Syndromes; Infections; Lamivudine; Liver Cirrhosis; Liver Failure; Liver Transplantation; Longitudinal Studies; Male; Middle Aged; Secondary Prevention; Treatment Outcome; Virus Diseases; Viruses

2010
Evaluating patients for second-line antiretroviral therapy in India: the role of targeted viral load testing.
    Journal of acquired immune deficiency syndromes (1999), 2010, Dec-15, Volume: 55, Issue:5

    Topics: Adult; Alkynes; Anti-HIV Agents; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Female; HIV; HIV Infections; Humans; India; Lamivudine; Male; Middle Aged; Nevirapine; RNA, Viral; Stavudine; Treatment Failure; Viral Load; Zidovudine

2010
Raltegravir and unboosted atazanavir dual therapy in virologically suppressed antiretroviral treatment-experienced HIV patients.
    Antiviral therapy, 2010, Volume: 15, Issue:7

    Topics: Adult; Aged; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Atazanavir Sulfate; CD4 Lymphocyte Count; Drug Interactions; Female; Follow-Up Studies; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Middle Aged; Oligopeptides; Pyridines; Pyrrolidinones; Raltegravir Potassium; Retrospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Viral Load

2010
Reduced dose of stavudine and lipoatrophy in HIV-infected patients in Cameroon.
    Antiviral therapy, 2010, Volume: 15, Issue:7

    Topics: Adult; Anti-HIV Agents; Cameroon; CD4 Lymphocyte Count; Cross-Sectional Studies; Female; HIV; HIV Infections; Humans; Lamivudine; Lipodystrophy; Male; Middle Aged; Nevirapine; Stavudine; Zidovudine

2010
A signal processing-based bioinformatics approach to assessing drug resistance: human immunodeficiency virus as a case study.
    Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2010, Volume: 2010

    Topics: Amino Acid Sequence; Anti-HIV Agents; Computational Biology; Drug Resistance; Enfuvirtide; HIV; HIV Envelope Protein gp41; HIV Infections; Humans; Lamivudine; Molecular Sequence Data; Mutation; Peptide Fragments; Phenylpropionates; Pyrimidines; Signal Processing, Computer-Assisted

2010
Self-reported adherence to HAART in South-Eastern Nigeria is related to patients' use of pill box.
    SAHARA J : journal of Social Aspects of HIV/AIDS Research Alliance, 2010, Volume: 7, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Aged; Algorithms; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Feasibility Studies; Female; HIV; HIV Infections; Humans; Lamivudine; Linear Models; Male; Medication Adherence; Middle Aged; Nevirapine; Nigeria; Patient Satisfaction; Prospective Studies; Reminder Systems; Risk Factors; Self Report; Stavudine; Surveys and Questionnaires; Treatment Outcome

2010
Interference of replication between hepatitis B and C viruses in patients infected with HIV.
    Journal of medical virology, 2011, Volume: 83, Issue:7

    Topics: Adult; Antibodies, Viral; CD4 Lymphocyte Count; Cell Line, Tumor; China; DNA, Viral; Female; Hepacivirus; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis C; HIV; HIV Infections; Humans; Lamivudine; Longitudinal Studies; Male; Mutation; Plasmids; Risk Factors; RNA, Viral; Transfection; Virus Replication

2011
Risk of liver-associated morbidity and mortality in a cohort of HIV and HBV coinfected Han Chinese.
    Infection, 2011, Volume: 39, Issue:5

    Topics: Adult; Alanine Transaminase; Anti-HIV Agents; CD4 Lymphocyte Count; China; Cohort Studies; Coinfection; DNA, Viral; Female; Hepatitis B; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Liver; Male; Middle Aged; Retrospective Studies; Risk Factors; RNA, Viral; Young Adult

2011
Gender difference in 2-year mortality and immunological response to ART in an HIV-infected Chinese population, 2006-2008.
    PloS one, 2011, Volume: 6, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Asian People; CD4 Lymphocyte Count; China; Female; Follow-Up Studies; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies; Sex Factors; Survival Rate; Treatment Outcome; Young Adult

2011
In vitro restoration of Th17 response during HIV infection with an antiretroviral drug and Th17 differentiation cytokines.
    AIDS research and human retroviruses, 2012, Volume: 28, Issue:8

    Topics: Anti-Retroviral Agents; CD4-Positive T-Lymphocytes; Cell Differentiation; Cells, Cultured; Cytokines; Flow Cytometry; HIV; HIV Infections; Humans; In Vitro Techniques; Lamivudine; Th17 Cells; Virus Replication

2012
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
    Liver international : official journal of the International Association for the Study of the Liver, 2012, Volume: 32, Issue:1

    Topics: Adenine; Adult; Anti-HIV Agents; Coinfection; Deoxycytidine; DNA Mutational Analysis; DNA, Viral; Drug Resistance, Viral; Drug Therapy, Combination; Emtricitabine; Female; Genotype; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Retrospective Studies; Tenofovir; Time Factors; Treatment Outcome

2012
Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
    Antiviral therapy, 2012, Volume: 17, Issue:1

    Topics: Adenine; Adult; Antiviral Agents; Cloning, Molecular; Coinfection; DNA, Viral; Drug Resistance, Viral; Female; Genotype; Hep G2 Cells; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation; Organophosphonates; Sequence Analysis, DNA; Tenofovir; Transfection

2012
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
    The Journal of antimicrobial chemotherapy, 2012, Volume: 67, Issue:6

    Topics: Adenine; Adult; Anti-HIV Agents; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; Female; France; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Mutation, Missense; Organophosphonates; Retrospective Studies; RNA, Viral; Selection, Genetic; Tenofovir; Treatment Failure; Viral Load

2012
Hepatitis B virus and human immunodeficiency virus drugs in pregnancy: findings from the Antiretroviral Pregnancy Registry.
    Journal of hepatology, 2012, Volume: 57, Issue:5

    Topics: Adenine; Adult; Antiviral Agents; Congenital Abnormalities; Female; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Phosphorous Acids; Pregnancy; Pregnancy Complications, Infectious; Prevalence; Prospective Studies; Registries; Retrospective Studies; Risk Factors; Treatment Outcome

2012
Influence of HIV-associated degree of immune suppression on molecular heterogeneity of hepatitis B virus among HIV co-infected patients.
    Virology, 2013, Feb-05, Volume: 436, Issue:1

    Topics: Adult; Amino Acid Sequence; Anti-HIV Agents; CD4 Lymphocyte Count; Coinfection; DNA, Viral; Female; Genetic Variation; Genotype; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; HIV; HIV Infections; Humans; Immunosuppression Therapy; Lamivudine; Male; Sequence Analysis, DNA; Viral Load

2013
Inhibition of telomerase activity by human immunodeficiency virus (HIV) nucleos(t)ide reverse transcriptase inhibitors: a potential factor contributing to HIV-associated accelerated aging.
    The Journal of infectious diseases, 2013, Volume: 207, Issue:7

    Topics: Adenine; Adult; Aging; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Cells, Cultured; Deoxycytidine; Dideoxynucleosides; Emtricitabine; Enzyme Activation; Female; HIV; HIV Infections; Humans; Lamivudine; Leukocytes, Mononuclear; Male; Middle Aged; Organophosphonates; Polymerase Chain Reaction; Regression Analysis; Reverse Transcriptase Inhibitors; Risk Factors; Telomerase; Telomere; Telomere Shortening; Tenofovir; Time Factors; Young Adult; Zidovudine

2013
Impaired 2',3'-dideoxy-3'-thiacytidine accumulation in T-lymphoblastoid cells as a mechanism of acquired resistance independent of multidrug resistant protein 4 with a possible role for ATP-binding cassette C11.
    The Biochemical journal, 2002, Nov-15, Volume: 368, Issue:Pt 1

    Topics: Anti-HIV Agents; ATP-Binding Cassette Transporters; Biological Transport; Deoxycytidine Kinase; Drug Resistance, Multiple; HIV; Humans; Lamivudine; Multidrug Resistance-Associated Proteins; Nucleosides; T-Lymphocytes; Tumor Cells, Cultured; Zidovudine

2002
Rheumatoid arthritis after 9 years of human immunodeficiency virus infection: possible contribution of tritherapy.
    The Journal of rheumatology, 2002, Volume: 29, Issue:10

    Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Arthritis, Reactive; HIV; HIV Infections; Humans; Immunocompromised Host; Lamivudine; Male; Saquinavir; Stavudine; Treatment Outcome

2002
[Exacerbation of chronic hepatitis B after discontinuing of antiretroviral therapy in HIV infection].
    Praxis, 2002, Dec-18, Volume: 91, Issue:51-52

    Topics: Adult; Anti-HIV Agents; Diagnosis, Differential; Female; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Time Factors; Virus Replication

2002
Treatment of chronic hepatitis B in the human immunodeficiency virus-infected patient: present and future.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2003, Dec-15, Volume: 37, Issue:12

    Topics: Adenine; Anti-HIV Agents; Antiviral Agents; Forecasting; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir

2003
In vitro activity of stampidine against primary clinical human immunodeficiency virus isolates.
    Arzneimittel-Forschung, 2004, Volume: 54, Issue:1

    Topics: Cells, Cultured; Dideoxynucleotides; Drug Resistance, Viral; Genotype; HIV; HIV Infections; HIV-1; Humans; Lamivudine; Mutation; Neutrophils; Phenotype; Reverse Transcriptase Inhibitors; Stavudine; Thymidine Monophosphate; Viral Plaque Assay; Zidovudine

2004
Antiretroviral therapy and HIV/hepatitis B virus coinfection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2004, Mar-01, Volume: 38 Suppl 2

    Topics: Adenine; Antiretroviral Therapy, Highly Active; Antiviral Agents; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Organophosphonates; Organophosphorus Compounds; Tenofovir

2004
Human immunodeficiency virus type 1 reverse transcriptase mutation selection during in vitro exposure to tenofovir alone or combined with abacavir or lamivudine.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:4

    Topics: Adenine; Anti-HIV Agents; Cloning, Molecular; Dideoxynucleosides; Drug Combinations; Drug Resistance, Viral; Genotype; HIV; HIV Reverse Transcriptase; Humans; Lamivudine; Mutation; Organophosphonates; Organophosphorus Compounds; Reverse Transcriptase Inhibitors; Tenofovir

2004
HIV/AIDS in China. A new treatment campaign, but with limited weapons.
    Science (New York, N.Y.), 2004, Jun-04, Volume: 304, Issue:5676

    Topics: Academies and Institutes; Acquired Immunodeficiency Syndrome; Anti-HIV Agents; China; Drug Costs; Drug Resistance, Viral; Drug Therapy, Combination; Foundations; HIV; HIV Infections; Humans; Lamivudine; Patents as Topic

2004
Simultaneous determination of the HIV nucleoside analogue reverse transcriptase inhibitors lamivudine, didanosine, stavudine, zidovudine and abacavir in human plasma by reversed phase high performance liquid chromatography.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2005, Feb-25, Volume: 816, Issue:1-2

    Topics: Anti-HIV Agents; Chromatography, High Pressure Liquid; Didanosine; Dideoxynucleosides; Drug Stability; HIV; HIV Infections; Humans; Lamivudine; Quality Control; Reproducibility of Results; Reverse Transcriptase Inhibitors; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Stavudine; Zidovudine

2005
Predictors of residual viremia in HIV-infected patients successfully treated with efavirenz and lamivudine plus either tenofovir or stavudine.
    The Journal of infectious diseases, 2005, Apr-01, Volume: 191, Issue:7

    Topics: Adenine; Adolescent; Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; DNA, Viral; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Multivariate Analysis; Organophosphonates; Oxazines; RNA, Viral; Stavudine; Tenofovir; Viremia

2005
Screen for underlying HIV before antiviral treatment for HBV.
    The Journal of infection, 2005, Volume: 51, Issue:2

    Topics: Adult; Antiretroviral Therapy, Highly Active; Contraindications; Drug Resistance, Viral; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Lamivudine; Male; Treatment Failure

2005
Severe efavirenz-induced hypersensitivity syndrome (not-DRESS) with acute renal failure.
    The Journal of infection, 2006, Volume: 52, Issue:2

    Topics: Acute Kidney Injury; Adenine; Adult; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Drug Hypersensitivity; Ghana; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Male; Mycobacterium tuberculosis; Organophosphonates; Reverse Transcriptase Inhibitors; Ritonavir; Tenofovir; Tuberculosis

2006
Treatment of lamivudine-resistant hepatitis B in HIV-infected persons: is adefovir dipivoxil the answer?
    Journal of hepatology, 2006, Volume: 44, Issue:1

    Topics: Adenine; AIDS-Related Opportunistic Infections; Antiviral Agents; DNA, Viral; Drug Resistance, Viral; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Antibodies; Humans; Lamivudine; Organophosphonates; Treatment Outcome

2006
Tenofovir DF and emtricitabine vs. zidovudine and lamivudine.
    The New England journal of medicine, 2006, Jun-08, Volume: 354, Issue:23

    Topics: Adenine; Bone Density; Deoxycytidine; Drug Resistance, Viral; Emtricitabine; HIV; HIV Infections; Humans; Lamivudine; Mutation; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir; Zidovudine

2006
Long-term follow-up of patients with initial early virologic failure after being treated with once-daily tenofovir/abacavir/lamivudine.
    AIDS patient care and STDs, 2006, Volume: 20, Issue:9

    Topics: Adenine; Anti-HIV Agents; Dideoxynucleosides; Drug Administration Schedule; Drug Resistance, Viral; Drug Therapy, Combination; Follow-Up Studies; HIV; HIV Infections; Humans; Lamivudine; Organophosphonates; RNA, Viral; Tenofovir; Treatment Failure

2006
Lamivudine-associated macrocytosis in HIV-infected patients.
    International journal of STD & AIDS, 2007, Volume: 18, Issue:1

    Topics: Adult; Anemia, Macrocytic; Erythrocyte Indices; Female; HIV; HIV Infections; Humans; Lamivudine; Male; Middle Aged; Retrospective Studies

2007
Reactivation of lamivudine-resistant occult hepatitis B in an HIV-infected patient undergoing cytotoxic chemotherapy.
    Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 2007, Volume: 39, Issue:1

    Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Drug Resistance, Viral; Hepatitis B; Hepatitis B virus; HIV; HIV Infections; Humans; Lamivudine; Lymphoma, Non-Hodgkin; Male; Virus Activation

2007
Population pharmacokinetics of lamivudine in human immunodeficiency virus-exposed and -infected infants.
    Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:12

    Topics: Anti-HIV Agents; Area Under Curve; Clinical Trials as Topic; Creatinine; Drug Administration Schedule; Female; HIV; HIV Infections; Humans; Infant; Infant, Newborn; Lamivudine; Male; Meta-Analysis as Topic; Metabolic Clearance Rate

2007
Efficacy and safety of a once daily regimen with efavirenz, lamivudine, and didanosine, with and without food, as initial therapy for HIV Infection: the ELADI study.
    AIDS research and human retroviruses, 2007, Volume: 23, Issue:10

    Topics: Adult; Alkynes; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclopropanes; Didanosine; Drug Administration Schedule; Female; Food; HIV; HIV Infections; Humans; Lamivudine; Male; Spain; Viral Load

2007
Tenofovir-based rescue therapy for advanced liver disease in 6 patients coinfected with HIV and hepatitis B virus and receiving lamivudine.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2008, Feb-01, Volume: 46, Issue:3

    Topics: Adenine; Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Viral; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Homosexuality, Male; Humans; Lamivudine; Liver Diseases; Male; Organophosphonates; Tenofovir; Transaminases; Viral Load

2008
Development of a population simulation model for HIV monotherapy virological outcomes using lamivudine.
    Antiviral chemistry & chemotherapy, 2007, Volume: 18, Issue:6

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Cytidine Triphosphate; Dideoxynucleotides; HIV; HIV Infections; Humans; Inhibitory Concentration 50; Kinetics; Lamivudine; Models, Biological; Monte Carlo Method; Reverse Transcriptase Inhibitors; Treatment Outcome; Viral Load

2007
Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinants.
    AIDS (London, England), 2008, Apr-23, Volume: 22, Issue:7

    Topics: Adult; Anti-Retroviral Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; Cote d'Ivoire; Drug Administration Schedule; Female; Follow-Up Studies; HIV; HIV Infections; HIV-1; HIV-2; Humans; Lamivudine; Male; Nevirapine; Survival Analysis; Treatment Outcome; Zidovudine

2008
AIDS mood upbeat--for a change.
    Science (New York, N.Y.), 1995, Feb-17, Volume: 267, Issue:5200

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Therapy, Combination; Gene Products, nef; Herpesviridae; HIV; Humans; Lamivudine; nef Gene Products, Human Immunodeficiency Virus; Sarcoma, Kaposi; Simian Immunodeficiency Virus; Virus Replication; Zalcitabine; Zidovudine

1995
New guidelines set for occupational HIV exposure.
    Lancet (London, England), 1996, Jul-06, Volume: 348, Issue:9019

    Topics: Accidents, Occupational; Antiviral Agents; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Practice Guidelines as Topic; Pyridines; Reverse Transcriptase Inhibitors; Zalcitabine; Zidovudine

1996
[HIV: less resistance due to combined treatment].
    Deutsche medizinische Wochenschrift (1946), 1996, Dec-06, Volume: 121, Issue:49

    Topics: Adult; Anti-HIV Agents; Computer Graphics; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Time Factors; Zidovudine

1996
[HIV: to administer protease inhibitors early].
    Deutsche medizinische Wochenschrift (1946), 1996, Dec-06, Volume: 121, Issue:49

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Ritonavir; Saquinavir; Time Factors; Zalcitabine; Zidovudine

1996
Correspondence between the effect of zidovudine plus lamivudine on plasma HIV level/CD4 lymphocyte count and the incidence of clinical disease in infected individuals. North American Lamivudine HIV Working Group.
    AIDS (London, England), 1997, Volume: 11, Issue:2

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Double-Blind Method; Drug Therapy, Combination; HIV; HIV Infections; Humans; Lamivudine; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Viral Load; Zidovudine

1997
A branched DNA signal amplification assay for quantification of nucleic acid targets below 100 molecules/ml.
    Nucleic acids research, 1997, Aug-01, Volume: 25, Issue:15

    Topics: Adenosine; Anti-HIV Agents; Cytidine; DNA; DNA, Viral; Drug Therapy, Combination; Guanosine; HIV; HIV Infections; Humans; Isoquinolines; Lamivudine; Nelfinavir; Nucleic Acid Hybridization; RNA, Viral; Sulfonic Acids; Zidovudine

1997
Cure or control of HIV/AIDS?
    Medical hypotheses, 1997, Volume: 48, Issue:6

    Topics: Acquired Immunodeficiency Syndrome; Anti-HIV Agents; Didanosine; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Models, Biological; Nevirapine; Pyridines; Ritonavir; Saquinavir; Stavudine; Zalcitabine; Zidovudine

1997
[Lamivudine treatment: realities and expectations].
    Gastroenterologia y hepatologia, 1997, Volume: 20, Issue:8

    Topics: Anti-HIV Agents; Antiviral Agents; DNA, Viral; Hepatitis B virus; Hepatitis B, Chronic; HIV; HIV Infections; Humans; Interferons; Lamivudine; Polymerase Chain Reaction

1997
Antiretroviral triple therapy decreases HIV viral load but does not alter hepatitis C virus (HCV) serum levels in HIV-HCV-co-infected haemophiliacs.
    AIDS (London, England), 1998, May-07, Volume: 12, Issue:7

    Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Cohort Studies; Drug Therapy, Combination; Hemophilia A; Hepacivirus; Hepatitis C; HIV; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Saquinavir; Stavudine; Treatment Outcome; Viral Load; Zidovudine

1998
Chemoprophylaxis after occupational exposure to human immunodeficiency virus in forensic autopsy.
    Nihon hoigaku zasshi = The Japanese journal of legal medicine, 1998, Volume: 52, Issue:2

    Topics: Anti-HIV Agents; Drug Therapy, Combination; Forensic Medicine; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Occupational Exposure; Zidovudine

1998
Antiretroviral drugs: new agents, new combinations line up against HIV.
    Hospital technology series, 1996, Volume: 15, Issue:1

    Topics: Antiviral Agents; Australia; Didanosine; Drug Therapy, Combination; Europe; HIV; HIV Infections; Humans; Lamivudine; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Reverse Transcriptase Inhibitors; Ritonavir; Thiazoles; United States; Valine; Zalcitabine; Zidovudine

1996
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens.
    JAMA, 2000, Jan-12, Volume: 283, Issue:2

    Topics: Anti-HIV Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Phenotype; RNA, Viral; Treatment Failure; Viral Load; Zidovudine

2000
Cutaneous side effects induced by indinavir.
    European journal of dermatology : EJD, 2000, Volume: 10, Issue:4

    Topics: Adult; Alopecia; Didanosine; Drug Eruptions; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Lipodystrophy; Male; Middle Aged; Pruritus; Pyoderma Gangrenosum; Retrospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Scalp Dermatoses; Skin; Stavudine; Zalcitabine; Zidovudine

2000
Failure to develop HIV infection after receipt of HIV-contaminated blood and postexposure prophylaxis.
    Annals of internal medicine, 2000, Jul-04, Volume: 133, Issue:1

    Topics: Adolescent; Anti-HIV Agents; Drug Administration Schedule; Drug Therapy, Combination; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Nelfinavir; Transfusion Reaction; Zidovudine

2000
Correlation between human immunodeficiency virus genotypic resistance and virologic response in patients receiving nelfinavir monotherapy or nelfinavir with lamivudine and zidovudine.
    The Journal of infectious diseases, 2000, Volume: 182, Issue:2

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Therapy, Combination; Genotype; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Mutation; Nelfinavir; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; RNA, Viral; Zidovudine

2000
Adherence, side effects and efficacy of stavudine plus lamivudine plus nelfinavir in treatment-experienced HIV-infected patients.
    The Journal of infection, 2000, Volume: 41, Issue:1

    Topics: Adult; CD4 Lymphocyte Count; Cohort Studies; Drug Therapy, Combination; Female; Hepatitis C; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Lamivudine; Logistic Models; Male; Nelfinavir; Patient Compliance; Polymerase Chain Reaction; Prospective Studies; Reverse Transcriptase Inhibitors; RNA, Viral; Statistics, Nonparametric; Stavudine; Substance Abuse, Intravenous

2000
[Prevalence of primary mutations in human immunodeficiency virus with resistance to nucleoside analogues in previously untreated patients from Andalusia. Andalusian Group for the Study of Infectious diseases (GAEI)].
    Medicina clinica, 2000, Oct-07, Volume: 115, Issue:11

    Topics: Adult; Anti-HIV Agents; CD4 Antigens; Codon; Data Interpretation, Statistical; DNA, Viral; Drug Resistance, Microbial; Female; Genotype; HIV; HIV Infections; Humans; Lamivudine; Male; Mutation; Polymerase Chain Reaction; Reverse Transcriptase Inhibitors; RNA, Viral; Spain; Viral Load; Zidovudine

2000
New antiretroviral strategies: interview with Marcus Conant, M.D. Interview by John S. James.
    AIDS treatment news, 1995, Aug-04, Issue:no 228

    Topics: Antiviral Agents; CD4 Lymphocyte Count; DNA, Viral; Drug Therapy, Combination; HIV; HIV Infections; Humans; Isoquinolines; Lamivudine; Peripheral Nervous System Diseases; Protease Inhibitors; Quinolines; Saquinavir; Stavudine; Zalcitabine; Zidovudine

1995
A Lisbon traviata. Are clinicians ready to sing addio to monotherapy and libiamo to combinations?
    Journal of the International Association of Physicians in AIDS Care, 1995, Volume: 1, Issue:8

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; HIV; HIV Infections; Humans; Hydroxyurea; Indinavir; Interleukin-2; Lamivudine; Mutation; Pyridines; RNA, Viral; Zalcitabine; Zidovudine

1995
Roaches of inner space.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; Lamivudine; Mutation; T-Lymphocytes, Cytotoxic; Virulence; Virus Replication; Zalcitabine; Zidovudine

1995
Conference looks at HIV drug resistance.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1995, Volume: 9, Issue:9

    Topics: Antiviral Agents; Carbamates; CD4 Lymphocyte Count; Drug Resistance, Microbial; Furans; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Sulfonamides; Thiazoles; Valine; Viremia; Zalcitabine; Zidovudine

1995
To treat or not to treat--approaches to antiretroviral therapy. Interview by Anthony J. Japour.
    AIDS clinical care, 1996, Volume: 8, Issue:1

    Topics: Acquired Immunodeficiency Syndrome; Antiviral Agents; CD4 Lymphocyte Count; Clinical Trials as Topic; Clinical Trials, Phase III as Topic; Didanosine; Drug Therapy, Combination; HIV; Humans; Lamivudine; Practice Patterns, Physicians'; RNA, Viral; Zalcitabine; Zidovudine

1996
Nipping HIV in the bud.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:8

    Topics: Antiviral Agents; CD4 Lymphocyte Count; Didanosine; DNA, Viral; Drug Resistance, Microbial; Drug Therapy, Combination; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Isoquinolines; Lamivudine; Pyridines; Quinolines; Ritonavir; Saquinavir; Stavudine; Thiazoles; Valine; Virus Replication; Zalcitabine; Zidovudine

1996
3TC treatment may slow HIV mutations, development of drug resistance.
    NIAID AIDS agenda, 1996

    Topics: Drug Resistance, Microbial; HIV; HIV Infections; Humans; Lamivudine; Mutation; Zalcitabine

1996
Outdated yet out-of-reach: AIDS society treatment guidelines at the International Conference.
    GMHC treatment issues : the Gay Men's Health Crisis newsletter of experimental AIDS therapies, 1996, Volume: 10, Issue:9

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Decision Making; Didanosine; Drug Therapy, Combination; HIV; HIV Infections; Humans; Lamivudine; Practice Guidelines as Topic; Zalcitabine; Zidovudine

1996
Update on antivirals.
    PI perspective, 1996, Issue:No 19

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; Drug Therapy, Combination; HIV; HIV Protease Inhibitors; Humans; Lamivudine; Reverse Transcriptase Inhibitors; RNA, Viral; Zidovudine

1996
NIAID researchers present new findings at retrovirus meeting. National Institute of Allergy and Infectious Diseases.
    NIAID AIDS agenda, 1997

    Topics: Anti-HIV Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chemokines; Clinical Trials as Topic; Clone Cells; Dendritic Cells; Didanosine; Disease Progression; Drug Therapy, Combination; Female; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Interleukin-10; Killer Cells, Natural; Lamivudine; Male; Nevirapine; Pyridines; Receptors, Cytokine; Reverse Transcriptase Inhibitors; Ritonavir; Virus Replication; Zalcitabine; Zidovudine

1997
New recommendations on health care worker exposure to HIV.
    STEP perspective, 1996,Fall, Volume: 8, Issue:3

    Topics: Anti-HIV Agents; Disease Transmission, Infectious; Drug Therapy, Combination; Guidelines as Topic; Health Personnel; HIV; HIV Infections; HIV Protease Inhibitors; Humans; Indinavir; Lamivudine; Occupational Exposure; Risk Factors; Viral Load; Zidovudine

1996
Prevalence and predictive value of intermittent viremia with combination hiv therapy.
    JAMA, 2001, Jul-11, Volume: 286, Issue:2

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Drug Resistance, Microbial; HIV; HIV Infections; Humans; Indinavir; Lamivudine; Predictive Value of Tests; Prevalence; Proportional Hazards Models; Retrospective Studies; RNA, Viral; Viral Load; Viremia; Virus Replication; Zidovudine

2001
Antiviral activity and intracellular metabolism of bis(tButylSATE) phosphotriester of beta-L-2',3'dideoxyadenosine, a potent inhibitor of HIV and HBV replication.
    Antiviral chemistry & chemotherapy, 2001, Volume: 12, Issue:2

    Topics: Animals; Anti-HIV Agents; Antiviral Agents; Chromatography, High Pressure Liquid; Dideoxyadenosine; Dideoxynucleotides; DNA-Directed DNA Polymerase; Half-Life; Hematopoietic Stem Cells; Hepatitis B virus; Hepatocytes; HIV; Humans; Inhibitory Concentration 50; Lamivudine; Leukocytes, Mononuclear; Marmota; Nucleic Acid Synthesis Inhibitors; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Tumor Cells, Cultured; Virus Replication

2001
Recent advances in the management and treatment of GI and hepatic diseases associated with HIV: Part 2.
    The AIDS reader, 2001, Volume: 11, Issue:8

    Topics: Amantadine; Antiviral Agents; Hepatitis B; Hepatitis C; HIV; HIV Infections; Humans; Interferon-alpha; Lamivudine; Risk Factors

2001
Transient relapses ("blips") of plasma HIV RNA levels during HAART are associated with drug resistance.
    Journal of acquired immune deficiency syndromes (1999), 2001, Oct-01, Volume: 28, Issue:2

    Topics: Anti-HIV Agents; Antiretroviral Therapy, Highly Active; CD4 Lymphocyte Count; HIV; HIV Infections; Humans; Lamivudine; Mutation; Recurrence; Reverse Transcriptase Polymerase Chain Reaction; RNA, Viral; Viral Load

2001
Lamivudine (Epivir).
    Research initiative, treatment action : RITA, 2000, Volume: 6, Issue:1

    Topics: Drug Resistance, Microbial; HIV; HIV Infections; Humans; Lamivudine; Practice Guidelines as Topic; Reverse Transcriptase Inhibitors

2000
Prediction of abacavir resistance from genotypic data: impact of zidovudine and lamivudine resistance in vitro and in vivo.
    Antimicrobial agents and chemotherapy, 2002, Volume: 46, Issue:1

    Topics: Algorithms; Anti-HIV Agents; Dideoxynucleosides; Drug Resistance, Microbial; Gene Frequency; Genotype; HIV; Humans; Lamivudine; Microbial Sensitivity Tests; Zidovudine

2002
Transmission of drug-resistant HIV after an occupational exposure despite postexposure prophylaxis with a combination drug regimen.
    Infection control and hospital epidemiology, 2002, Volume: 23, Issue:6

    Topics: Adult; Anti-HIV Agents; Health Personnel; HIV; HIV Infections; Humans; Infectious Disease Transmission, Patient-to-Professional; Lamivudine; Needlestick Injuries; Occupational Exposure; Treatment Failure; Zidovudine

2002
Selective inhibition of human immunodeficiency viruses by racemates and enantiomers of cis-5-fluoro-1-[2-(hydroxymethyl)-1,3-oxathiolan-5-yl]cytosine.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:11

    Topics: Antiviral Agents; Emtricitabine; HIV; HIV Reverse Transcriptase; HIV-1; HIV-2; Humans; Lamivudine; Reverse Transcriptase Inhibitors; Stereoisomerism; Zalcitabine; Zidovudine

1992
Effects of (-)-2'-deoxy-3'-thiacytidine (3TC) 5'-triphosphate on human immunodeficiency virus reverse transcriptase and mammalian DNA polymerases alpha, beta, and gamma.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:8

    Topics: Antiviral Agents; Base Sequence; DNA Polymerase I; DNA Polymerase II; DNA Polymerase III; DNA-Directed DNA Polymerase; HIV; Kinetics; Lamivudine; Molecular Sequence Data; Nucleic Acid Synthesis Inhibitors; Nucleotides; Peptide Chain Termination, Translational; Polyribonucleotides; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Zalcitabine

1992